Navigation Links
Halozyme Provides Update on ViroPharma Phase 2 Trial of Subcutaneous Cinryze (C1 Esterase Inhibitor [Human]) Formulation with rHuPH20
Date:8/1/2013

lozyme's pipeline addresses therapeutic areas, including diabetes, oncology and dermatology that have significant unmet medical need. The Company markets Hylenex® recombinant (hyaluronidase human injection) and has partnerships with Roche, Pfizer, Baxter, ViroPharma and Intrexon. Halozyme is headquartered in San Diego, CA. For more information on how we are innovating, please visit our corporate website at www.halozyme.com.

Halozyme Safe Harbor Statement

In addition to historical information, the statements set forth above include forward-looking statements including, without limitation, statements concerning our product candidates in development, potential benefits and attributes of rHuPH20 and our product candidates including safety and clinical profile, anticipated clinical and regulatory events and our intended actions, that involve risk and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. The forward-looking statements are usually (but not always) identified through use of the words "believe," "enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict," "probable," "potential," "possible," "should," "continue," and other words of similar meaning.  Actual results could differ materially from the expectations contained in forward-looking statements as a result of risks and uncertainties including clinical trial enrollment and results, regulatory approval requirements, unexpected expenditures and costs, unexpected results or delays in development and regulatory review, unexpected adverse events and competitive conditions. These and other factors that may result in differences are discussed in greater detail in the Company's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 8, 2013. Halozyme does not undertake to
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Halozyme to Host Second Quarter 2013 Financial Results Conference Call
2. Halozymes Phase 1b Clinical Trial Of PEGPH20 With Gemcitabine Indicates Positive Activity Against Pancreatic Cancer
3. Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer
4. Halozyme Reports First Quarter 2013 Financial Results
5. Halozyme Therapeutics To Present At The Bank Of America Merrill Lynch 2013 Health Care Conference
6. Halozyme Therapeutics Names Matt Posard to Board of Directors
7. Baxter And Halozyme Announce Positive Opinion For HyQvia For Treatment Of Primary And Secondary Immunodeficiencies In The European Union
8. Halozyme Therapeutics to Present at the Barclays 2013 Global Healthcare Conference
9. Halozyme Reports Fourth Quarter and Year End 2012 Financial Results
10. Halozyme Announced Roche Filed A Marketing Authorization Application For Subcutaneous MabThera
11. Halozyme Therapeutics To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 2014 Transparency Market ... Acid (MCA) Market for Cellulosics, Agrochemicals, Surfactants, Thioglycolic Acid ... Share, Growth, Trends and Forecast 2014 - 2020". The ... million in 2013 and is anticipated to reach USD ... 3.6% during the forecast period from 2014 to 2020. ...
(Date:8/20/2014)... NEW YORK , Aug. 20, 2014 ... market research report is available in its ... (The Market for Bluetooth, RFID, Zigbee, UWB ... http://www.reportlinker.com/p0652514/Wireless-Opportunities-in-Healthcare-The-Market-for-Bluetooth-RFID-Zigbee-UWB-WWAN-WMAN-WLAN-and-other-technologies.html ... Market for Bluetooth, RFID, Zigbee, UWB WWAN, ...
(Date:8/20/2014)... Aug. 20, 2014   Ventana Medical Systems, ... today announced that its VENTANA System for Primary ... the European Union for routine pathology, including primary ... of VENTANA Virtuoso software coupled with either the ... slide scanner, provides automated digital slide creation, case ...
Breaking Medicine Technology:Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 2Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 3Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 4Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 2Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 3Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 4Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 5Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 6Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 7Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 8Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 9Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 10Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 11Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 12Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 13Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 14Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 15Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 16Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 3
... PHILADELPHIA, October 13 Shire plc (LSE: ... announces,that it has settled all pending litigation with Sandoz, ... ("ANDA") and its,attempt to market generic versions of Shire,s ... Deficit Hyperactivity,Disorder. , The settlement ...
... NUREMBERG, Germany, October 13 ... "2009 European Mobile C-arms Business,Development Strategy Leadership Award" from ... recognizes the successful growth strategy,of the technology leader in ... the opening up of important new markets, as well ...
Cached Medicine Technology:Shire and Sandoz Settle all Pending Litigation Concerning ADDERALL XR(R) 2Shire and Sandoz Settle all Pending Litigation Concerning ADDERALL XR(R) 3Award-Winning Medical Technology From Germany 2Award-Winning Medical Technology From Germany 3
(Date:8/20/2014)... August 20, 2014 Biocide Systems ... on Wrench Advisors as a consultant and partner ... large accounts. , As Wrench Advisors explains on ... help your organization plan and execute programs by ... distribution channels. Our experience developing joint venture partnerships ...
(Date:8/20/2014)... August 20, 2014 The Academy of ... Lokhandwala, DDS, FAGD of Starbrite Dental in Fremont, California, ... 2014 Annual Meeting & Exhibits, which took place June ... presented to dentists who seek to provide the highest-quality ... earn this prestigious honor, Dr. Lokhandwala completed 500 hours ...
(Date:8/20/2014)... don,t get enough sleep may wake up to worse ... new research, risk of being obese by age 21 ... than six hours of sleep a night, compared with ... Centers for Disease Control and Prevention recommends nine to ... the Mailman School of Public Health at Columbia University ...
(Date:8/20/2014)... FL (PRWEB) August 20, 2014 Ticket Down ... tickets in Miami, FL at the Sun Life Stadium in ... football rivalry this September when Brazil and Colombia meet at Sun ... of the top 10 teams in the world and will be ... in Brazil. The match will kick-off on Sept. 5 and will ...
(Date:8/20/2014)... The finalists are in for the sixth-annual ... magazine, will honor the pharmaceutical industry’s most influential innovators. ... outstanding companies, marketers and brand managers representing the best ... proud to announce that we received our biggest response ... number of submissions we received last year,” says Anna ...
Breaking Medicine News(10 mins):Health News:Biocide Systems Announces Partnership with Wrench Advisors 2Health News:Fremont Dentist Receives Prestigious AGD Fellowship Award 2Health News:Teen sleeplessness piles on risk for obesity 2Health News:Brazil vs. Colombia Tickets in Miami, FL: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Match 2Health News:Brazil vs. Colombia Tickets in Miami, FL: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Match 3Health News:PM360 Announces 2014 Trailblazer Award Finalists 2Health News:PM360 Announces 2014 Trailblazer Award Finalists 3Health News:PM360 Announces 2014 Trailblazer Award Finalists 4Health News:PM360 Announces 2014 Trailblazer Award Finalists 5Health News:PM360 Announces 2014 Trailblazer Award Finalists 6Health News:PM360 Announces 2014 Trailblazer Award Finalists 7Health News:PM360 Announces 2014 Trailblazer Award Finalists 8
... Intelligent Order Routing allows hospital pharmacies to design their ... , , ROSEMONT, Ill., June 15 ... Inc., (Nasdaq: OMCL ) a leading provider ... the Omnicell WorkflowRx (TM) 6.0 central ...
... UTRECHT, The Netherlands, June 15 The largest global,study ... that strongly connected people have more enjoyment in their ... but more successful. Strongly,connected people have a better idea ... achieve it. The study, carried out by &intoconnection, proves ...
... HILLS, Mass., June 15 Joseph F. Finn, Jr., C.P.A. ("Finn") ... to and blocks the effects of galectin-3. Galectin-3 plays an ... proliferation and tumor metastasis, which is the spread of cancer beyond ... have multiple benefits in combating cancer cells, including: , , ...
... software platform and internal support for DailyMed Pharmacy , ... debt , , INDIANAPOLIS, June 15 Arcadia Resources, ... of home care, medical staffing, and pharmacy services under the ... retail pharmacy management software business. , , Arcadia ...
... and Media , , PHILADELPHIA, June 15 , , ... assistance and international healthcare, and provider of pandemic, ... companies, around the globe:, ... outbreak and, pandemic specialist, ...
... ... of 2009 "Best in KLAS" vendors , ... Orem, UT (PRWEB) June 15, 2009 -- Healthcare research firm ... in seven key market categories - including computed tomography (CT), digital mammography, smart pumps ...
Cached Medicine News:Health News:Omnicell Boosts Pharmacy Efficiency with Enhanced WorkflowRx(TM) Central Pharmacy Automation Software 2Health News:Omnicell Boosts Pharmacy Efficiency with Enhanced WorkflowRx(TM) Central Pharmacy Automation Software 3Health News:Scientific Study Makes it Possible to Measure Connection Between People 2Health News:Scientific Study Makes it Possible to Measure Connection Between People 3Health News:Prospect Therapeutics' In Vitro Studies Demonstrate that GCS-100 Drug Binds to and Blocks the Effects of Galectin-3 2Health News:Arcadia Resources Sells Non-Core Software Business 2Health News:Arcadia Resources Sells Non-Core Software Business 3Health News:Doctor, Pandemic Planning Expert to Host Webinar on Influenza H1N1 2Health News:Doctor, Pandemic Planning Expert to Host Webinar on Influenza H1N1 3Health News:Doctor, Pandemic Planning Expert to Host Webinar on Influenza H1N1 4Health News:Top-Performing Medical Equipment Companies Announced 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: